Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

MDI seeks licensees for antiacne compounds

Jan. 22, 1997

Hyal receives patent protection for most advanced product

Jan. 22, 1997

New wound-healing agents reported

Jan. 20, 1997

FDA approves topical acne treatment

Jan. 17, 1997

Gliatech licenses ADCON products in Japan

Jan. 14, 1997

Carrington Laboratories enters Middle East and African markets

Jan. 14, 1997

Allergan claims retinoid-like compounds

Jan. 13, 1997

Cariel trial initiated

Jan. 9, 1997

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

Study results reported for Immune Response antipsoriatic agent

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...